Contrast Media Injectors Market

Executive Summary

Contrast Media Injectors Market was valued at US $1.05 billion in 2021 and is projected to grow at 5.14% CAGR over the forecast period to reach US $1.42 billion by 2027. Contrast Media Injectors Market represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.37 billion opportunity in 2027 over 2021.

Contrast Media Injectors from Consainsights analyses the Contrast Media Injectors Market in the Life Sciences industry over the forecast period to 2027.

Contrast Media Injectors research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Contrast Media Injectors segmentation includes Product, Application, End User and Geography.

Based on the Product, the Contrast Media Injectors analysis covers Consumables, Injector Systems, Accessories.

In Product segment, Consumables segment has highest cagr growth of 4.56%.

Based on the Application, the Contrast Media Injectors analysis covers Radiology, Interventional Cardiology, Interventional Radiology.

In Application segment, Radiology segment has highest cagr growth of 4.56%.

Based on the End User, the Contrast Media Injectors analysis covers Hospitals, Diagnostic Imaging Centers.

In End User segment, Hospitals segment has highest cagr growth of 4.56%.

Based on the region, the Contrast Media Injectors analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Bayer Ag, Bracco Imaging S.P.A, Guerbet Group, Shenzhen Anke High-tech Co., Ltd., Nemoto Kyorindo Co., Ltd., Sino Medical Device Technology Co., Ltd., Apollo Rt Co., Ltd., Shenzhen Seacrown Electromechanical Co. Ltd., Ulrich Gmbh & Co. Kg., Medtron Ag and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Consumables segment has the highest revenue of US $0.64 billion and is expected to grow at CAGR of 4.56% by 2027 Consumables segment has highest cagr growth of 4.56%.

Consumables

Consumables segment was valued at US $0.58 billion in 2019 and is projected to grow at 4.56% CAGR over the forecast period to reach US $0.87 billion by 2027. Consumables segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.23 billion opportunity in 2027 over 2021.

Injector Systems

Injector Systems segment was valued at US $0.23 billion in 2019 and is projected to grow at 4.56% CAGR over the forecast period to reach US $0.35 billion by 2027. Injector Systems segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.09 billion opportunity in 2027 over 2021.

Accessories

Accessories segment was valued at US $0.13 billion in 2019 and is projected to grow at 4.56% CAGR over the forecast period to reach US $0.20 billion by 2027. Accessories segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.05 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Radiology segment has the highest revenue of US $0.64 billion and is expected to grow at CAGR of 4.56% by 2027 Radiology segment has highest cagr growth of 4.56%.

Radiology

Radiology segment was valued at US $0.58 billion in 2019 and is projected to grow at 4.56% CAGR over the forecast period to reach US $0.86 billion by 2027. Radiology segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.22 billion opportunity in 2027 over 2021.

Interventional Cardiology

Interventional Cardiology segment was valued at US $0.28 billion in 2019 and is projected to grow at 4.56% CAGR over the forecast period to reach US $0.42 billion by 2027. Interventional Cardiology segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.11 billion opportunity in 2027 over 2021.

Interventional Radiology

Interventional Radiology segment was valued at US $0.09 billion in 2019 and is projected to grow at 4.56% CAGR over the forecast period to reach US $0.13 billion by 2027. Interventional Radiology segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.03 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals segment has the highest revenue of US $0.88 billion and is expected to grow at CAGR of 4.56% by 2027 Hospitals segment has highest cagr growth of 4.56%.

Hospitals

Hospitals segment was valued at US $0.80 billion in 2019 and is projected to grow at 4.56% CAGR over the forecast period to reach US $1.19 billion by 2027. Hospitals segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.31 billion opportunity in 2027 over 2021.

Diagnostic Imaging Centers

Diagnostic Imaging Centers segment was valued at US $0.15 billion in 2019 and is projected to grow at 4.56% CAGR over the forecast period to reach US $0.23 billion by 2027. Diagnostic Imaging Centers segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.06 billion opportunity in 2027 over 2021.